Authors' Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.

MLA

Pope, Janet, et al. “Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.” Advances in Therapy, vol. 38, no. 5, May 2021, pp. 2750–56. EBSCOhost, https://doi.org/10.1007/s12325-021-01642-9.

APA

Pope, J., Sawant, R., Tundia, N., Du, E. X., Qi, C. Z., Song, Y., Tang, P., & Betts, K. A. (2021). Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis. Advances in Therapy, 38(5), 2750–2756. https://doi.org/10.1007/s12325-021-01642-9

Chicago

Pope, Janet, Ruta Sawant, Namita Tundia, Ella X Du, Cynthia Z Qi, Yan Song, Patrick Tang, and Keith A Betts. 2021. “Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.” Advances in Therapy 38 (5): 2750–56. doi:10.1007/s12325-021-01642-9.